CBIO
Income statement / Annual
Last year (2022), Catalyst Biosciences, Inc.'s total revenue was $794,000.00,
a decrease of 89.18% from the previous year.
In 2022, Catalyst Biosciences, Inc.'s net income was -$8.24 M.
See Catalyst Biosciences, Inc.�s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
Operating Revenue |
$794,000.00
|
$7.34 M
|
$20.95 M
|
$0.00
|
$6,000.00
|
$1.02 M
|
$399,000.00
|
$1.75 M
|
$275,000.00
|
$3.63 M
|
Cost of Revenue |
$798,000.00 |
$7.38 M |
$9.16 M |
$43.86 M |
$21.47 M |
$12.85 M |
$10.56 M |
$5.96 M |
$5.27 M |
$6.56 M |
Gross Profit |
-$4,000.00 |
-$42,000.00 |
$11.79 M |
-$43.86 M |
-$21.47 M |
-$11.83 M |
-$10.16 M |
-$4.21 M |
-$4.99 M |
-$2.93 M |
Gross Profit Ratio |
-0.01 |
-0.01 |
0.56 |
0 |
-3578 |
-11.62 |
-25.45 |
-2.4 |
-18.15 |
-0.81 |
Research and Development
Expenses |
$13.04 M
|
$68.89 M
|
$52.98 M
|
$43.86 M
|
$21.47 M
|
$12.85 M
|
$11.56 M
|
$5.96 M
|
$19.50 M
|
$38.84 M
|
General & Administrative
Expenses |
$17.37 M
|
$18.96 M
|
$16.18 M
|
$13.42 M
|
$12.35 M
|
$9.99 M
|
$9.26 M
|
$9.59 M
|
$10.17 M
|
$12.01 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$17.37 M
|
$18.96 M
|
$16.18 M
|
$13.42 M
|
$12.35 M
|
$9.99 M
|
$9.26 M
|
$9.59 M
|
$10.17 M
|
$12.01 M
|
Other Expenses |
$0.00 |
-$78,000.00 |
$568,000.00 |
-$46,000.00 |
$1.65 M |
$261,000.00 |
$86,000.00 |
$0.00 |
$318,000.00 |
$518,000.00 |
Operating Expenses |
$30.40 M |
$87.85 M |
$69.16 M |
$57.28 M |
$33.83 M |
$22.84 M |
$20.82 M |
$15.55 M |
$29.67 M |
$50.85 M |
Cost And Expenses |
$31.20 M |
$95.23 M |
$78.32 M |
$57.28 M |
$33.83 M |
$22.84 M |
$20.82 M |
$15.55 M |
$29.67 M |
$50.85 M |
Interest Income |
$537,000.00 |
$39,000.00 |
$1.13 M |
$2.10 M |
$3.77 M |
$261,000.00 |
$3.47 M |
$518,000.00 |
$585,000.00 |
$784,000.00 |
Interest Expense |
$717,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$1.48 M |
$23,000.00 |
$53,000.00 |
Depreciation &
Amortization |
-$43.54 M
|
$290,000.00
|
$138,000.00
|
$146,000.00
|
$149,000.00
|
$173,000.00
|
$389,000.00
|
$470,000.00
|
$351,000.00
|
$547,000.00
|
EBITDA |
-$52.15 M
|
-$87.60 M
|
-$57.37 M
|
-$57.28 M
|
-$33.82 M
|
-$21.82 M
|
-$16.95 M
|
-$12.81 M
|
-$28.46 M
|
-$47.22 M
|
EBITDA Ratio |
-65.68 |
-11.94 |
-2.74 |
0 |
-5637 |
-21.44 |
-42.47 |
-7.32 |
-103.49 |
-13.01 |
Operating Income Ratio
|
-10.85
|
-11.98
|
-2.74
|
0
|
-5637
|
-21.44
|
-51.17
|
-7.89
|
-108.05
|
-13.01
|
Total Other
Income/Expenses Net |
$717,000.00
|
-$39,000.00
|
$1.13 M
|
$2.10 M
|
$3.77 M
|
$261,000.00
|
$3.47 M
|
-$960,000.00
|
$575,000.00
|
$518,000.00
|
Income Before Tax |
-$7.89 M |
-$87.93 M |
-$56.24 M |
-$55.18 M |
-$30.06 M |
-$21.56 M |
-$16.95 M |
-$14.76 M |
-$29.14 M |
-$46.70 M |
Income Before Tax Ratio
|
-9.94
|
-11.98
|
-2.68
|
0
|
-5009.17
|
-21.18
|
-42.47
|
-8.44
|
-105.96
|
-12.87
|
Income Tax Expense |
$348,000.00 |
-$39,000.00 |
-$699,000.00 |
-$2.29 M |
$3.77 M |
-$173,000.00 |
$3.08 M |
$518,000.00 |
$3.48 M |
$7,000.00 |
Net Income |
-$8.24 M |
-$87.89 M |
-$55.54 M |
-$52.89 M |
-$30.06 M |
-$21.56 M |
-$16.95 M |
-$14.76 M |
-$32.62 M |
-$46.71 M |
Net Income Ratio |
-10.38 |
-11.98 |
-2.65 |
0 |
-5009.17 |
-21.18 |
-42.47 |
-8.44 |
-118.63 |
-12.87 |
EPS |
-0.26 |
-2.87 |
-2.9 |
-4.41 |
-2.68 |
-6.3 |
-21.76 |
-49.99 |
-101.4 |
-145.78 |
EPS Diluted |
-0.26 |
-2.87 |
-2.9 |
-4.41 |
-2.68 |
-6.3 |
-21.76 |
-49.99 |
-101.4 |
-145.78 |
Weighted Average Shares
Out |
$31.55 M
|
$30.64 M
|
$19.18 M
|
$12.00 M
|
$11.21 M
|
$3.42 M
|
$778,780.00
|
$295,272.00
|
$321,719.00
|
$320,385.00
|
Weighted Average Shares
Out Diluted |
$31.55 M
|
$30.64 M
|
$19.18 M
|
$12.00 M
|
$11.21 M
|
$3.42 M
|
$778,780.00
|
$295,272.00
|
$321,719.00
|
$320,385.00
|
Link |
|
|
|
|
|
|
|
|
|
|